Posted: 05-Mar-25
Location: Philadelphia, Pennsylvania
Type: Full Time
Categories:
Sector:
Internal Number: -
The Opportunity
The Fox Chase Cancer Center has partnered with AMN Healthcare to recruit the next Chief of Endocrinology. This is an exciting opportunity for an accomplished academic endocrinologist to lead and further advance an established, high-performing program at an outstanding NCI-designated comprehensive cancer center.
Reporting to Dr. David Weinberg, Chair, Department of Medicine and Audrey Weg Schaus and Geoffrey Alan Weg Chair in Medical Science at Fox Chase Cancer Center, the new leader will oversee the research portfolio and all clinical and educational activities of the division. The chief will have resources to support the mentorship, recruitment and retention of faculty and will additionally manage financial resources. This Chief of Endocrinology will be a key member of a busy clinical group, collaborating within a multidisciplinary environment and will help develop research programs within endocrinology. There is also a significant opportunity to further develop subspecialty programs.
As an NCI-designated cancer, Fox Chase Cancer Center presents a unique opportunity for an academic endocrinologist to treat a wide variety of pathologies both related and unrelated to cancer. The Chief of Endocrinology will lead a team with a significant role in providing comprehensive care, treating all benign and malignant endocrine conditions, including the acute and chronic effects of cancer and cancer related therapies. At Fox Chase, and in conjunction with clinicians and investigators across the Temple Health System, there are outstanding opportunities to pursue meaningful clinical and research collaboration.
With the resources and support from the Department of Medicine and other Fox Chase leaders, the new Division Chief will be well situated to deliver on stated goals: elevating and further developing the division’s research portfolio; recruiting, mentoring, and retaining outstanding faculty; managing efficient clinical operations; and nurturing existing relationships with the opportunity to expand the clinical footprint across the growing enterprise. The new chief will also be supported in achieving personal development and academic goals.
Division of Endocrinology: The Division of Endocrinology is a growing division with the opportunity to expand at Fox Chase’s primary location but also to new satellite facilities. The program provides comprehensive evaluation and treatment of patients with endocrine neoplasms, including thyroid, parathyroid, adrenal, pituitary, and neuroendocrine. These specialists also study, manage and treat the consequences of cancer treatment. The clinical practice trends towards less focus on diabetes management.
Endocrinology faculty members are dedicated to excellent clinical care, inquiry and innovation, and this is a wonderful opportunity to build upon and expand the research footprint of the Division. With over 150 funded FCCC researchers, a large immunotherapy program across all of medical oncology with potential expanded linkage to the Temple campus, strong head and neck, urology and other specialty cancer programs, there is ample opportunity for collaboration.
The Organization
Fox Chase Cancer Center: Fox Chase Cancer Center (FCCC) is a pioneering institution in cancer research, treatment, and patient care. With a legacy spanning over a century, it has consistently upheld its commitment to pushing the boundaries of scientific understanding while providing hope and healing to cancer patients. One of only two NCI-designated Comprehensive Cancer Centers in the Philadelphia region, FCCC is a founding member of the National Comprehensive Cancer Network.
The affiliation of FCCC with Temple University and Temple University Health System and the Lewis Katz School of Medicine began in 2012. Through this arrangement, Fox Chase combines the flexibility of a free-standing cancer center with the scientific and clinical power of a large academic health system.
The Temple University Health System has committed $100M in support to Fox Chase over the next five years and is making capital upgrades and investments in new technology and enhancement to the physical plant. The past few years have seen significant advances in Fox Chase’s clinical, operational, research, and financial performance. Al-together, this commitment is leading to significant advances in patient experience, enhanced access to therapies, better outcomes, and more efficient processes to further accelerate the pace of cancer discovery and delivery.
The Position
The successful candidate must be collaborative and able to support an efficient and effective Department with the highest standards of clinical outcomes and research impact in a complex patient-centered, mission-driven, academic environment. environment. The Division Chief will exhibit values consistent with the mission of TUHS and FCCC and the drive towards collaboration, Inclusion, and service to improve the health and well-being of individuals and communities.
- Support the academic tripartite mission as a visible and collaborative leader who stands as an advocate for patients, learners, staff, and faculty members.
- Drive standardization and integration of clinical services.
- Support educational programs.
- Mentor, recruit and retain faculty.
- Promote productive collaborations between clinical and basic science research efforts to enhance the overall volume and scientific quality of translational re-search.
- Represent the organization to the community to enhance goodwill and positive community relations.
- Elevating and further developing the Division’s research portfolio.
Education and Qualifications
- MD, DO or MD/PhD
- Fellowship trained and Board certified in Endocrinology
- A record of achievement suitable for appointment as Associate Professor or Professor
- Eligible for licensure in the Commonwealth of Pennsylvania
The Region
Philadelphia is one of the most historically significant cities in the United States and served as the nation’s capital until 1800. Philadelphia is the nation’s sixth-most populous city with a population of approximately 1.6 million.
Fox Chase Cancer Center is located in a residential neighborhood in Northeast Philadelphia, Pennsylvania, on the border of Bucks, Montgomery, and Philadelphia counties. The closest neighborhoods to the center are Fox Chase, Rockledge, Cheltenham, Jenkintown, and Mayfair. The area offers many housing options, including quiet suburban living and trendy urban neighborhoods, and housing is generally more affordable than in other major Northeastern cities.
Process for Application
Application materials should include the following: a current curriculum vitae and a comprehensive letter of interest summarizing all relevant experience, leadership accomplishments, philosophy, clinical, educational, research interests, experience promoting diversity and inclusion at their current institution as well as how that experience will add value to Temple Health and Fox Chase Cancer Center. Please direct any potential interest and/or nominations to:
Erika Warren
Consultant
AMN Healthcare
Physician and Leadership Solutions
Erika.Warren@amnhealthcare.com
To offer a confidential nomination:
Fox Chase Cancer Center – Division Chief, Endocrinology Nominations